AVID100 in Advanced Epithelial Carcinomas
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Solid Tumor, Adult|Triple Negative Breast Cancer|Head and Neck Squamous Cell Carcinoma|Non Small Cell Lung Cancer
Interventions: DRUG: AVID100 IV
Sponsor: Formation Biologics